In vitro studies with colon cancer cell lines, using siRNA, showed that HIPK2 silencing is associated with increased PGE2 biosynthesis that was profoundly suppressed by the cPLA2 inhibitor. This evidence concerns the gene PLA2G4A and colonic neoplasm.